16 nov 2020 anni - Moderna publishes clinical trial results showing 94.5% efficacy for their mRNA vaccine. FDA promises to move quickly in granting EUAs to Pfizer and Moderna while the companies continue with their Phase III trials. Pfizer announces 95% efficacy for their mRNA vaccine.